Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1075022 Target Snapshot

ParE · SINGLE PROTEIN · Streptococcus pneumoniae

35Compounds
1Assays
1Approved Drugs
35.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q7X1P7. Use UniProt Q7X1P7 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q7X1P7 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats ParE as ChEMBL target CHEMBL1075022, mapped to UniProt Q7X1P7. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
ParE
SINGLE PROTEIN · Streptococcus pneumoniae
As of 2026-09-14
ChEMBL target ID
CHEMBL1075022
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q7X1P7
DNA topoisomerase (ATP-hydrolyzing)
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether ParE is the right protein anchor across sources, using UniProt Q7X1P7 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDNA topoisomerase (ATP-hydrolyzing)
UniProt AccessionQ7X1P7
Component TypeProtein
Sequence Length638 aa

DNA topoisomerase (ATP-hydrolyzing)

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as ParE, mapped to UniProt Q7X1P7. ChEMBL maps the protein component as DNA topoisomerase (ATP-hydrolyzing). Sequence length is 638 aa.

Mapped IDQ7X1P7
Review nameParE
OrganismStreptococcus pneumoniae
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC5035.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL568020 6.92 IC50 119.0 Preclinical
CHEMBL565776 6.83 IC50 147.0 Preclinical
CHEMBL577478 6.6 IC50 250.0 Preclinical
CHEMBL578362 6.59 IC50 258.0 Preclinical
CHEMBL578120 6.58 IC50 265.0 Preclinical
CHEMBL578361 6.55 IC50 280.0 Preclinical
CHEMBL567804 6.44 IC50 366.0 Preclinical
CHEMBL583049 6.44 IC50 364.0 Preclinical
CHEMBL565572 6.43 IC50 367.0 Preclinical
CHEMBL568021 6.43 IC50 373.0 Preclinical
Distribution

pChEMBL Value Distribution

6
5.0
7
5.5
16
6.0
6
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

1
Total Assays
35
Tested Compounds
1
Assay Types
Binding — 1 assays, 35 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1 35 6.1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine